Protein & Peptide Letters
Title:Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential
Volume: 24 Issue: 8
Author(s): Razvan T. Radulescu*
Affiliation:
- Molecular Concepts Research (MCR), Münster/Westfalen,Germany
Export Options
About this article
Cite this article as:
Radulescu T. Razvan *, Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential, Protein & Peptide Letters 2017; 24 (8) . https://dx.doi.org/10.2174/0929866524666170830124707
DOI https://dx.doi.org/10.2174/0929866524666170830124707 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enediyne Anticancer Antibiotic Lidamycin: Chemistry, Biology and Pharmacology
Anti-Cancer Agents in Medicinal Chemistry Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
CNS & Neurological Disorders - Drug Targets Proteasomes: A Complex Story
Current Protein & Peptide Science Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design New Framework for the Discovery of PRC2 Inhibitors: Epigenetic Drugs
Current Drug Targets Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets Hsp90 Inhibition with Resorcylic Acid Lactones (RALs)
Current Topics in Medicinal Chemistry Enjoy the Silence: The Story of let-7 MicroRNA and Cancer
Current Genomics G4 Aptamers: Trends in Structural Design
Mini-Reviews in Medicinal Chemistry Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Basal Breast Cancer: A Complex and Deadly Molecular Subtype
Current Molecular Medicine Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design The Current and Future Therapies for Human Osteosarcoma
Current Cancer Therapy Reviews Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design Polyphyllin I Induces Cell Cycle Arrest and Cell Apoptosis in Human Retinoblastoma Y-79 Cells through Targeting p53
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Fate Decisions: The Role of Heparan Sulfate in the Control of Autocrine and Paracrine Signals
Current Stem Cell Research & Therapy Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions
Current Medicinal Chemistry Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
Current Medicinal Chemistry MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers
Current Cancer Therapy Reviews